CASC3 and Miyoshi myopathy: Thus, it is likely that cells from BP-Btz-treated mice have a higher osteoblast differentiation potential than cells from Btz-treated mice because BP-Btz kills more MM cells and perhaps has stronger effects on osteoblast precursors due its delivery of a higher local concentration of Btz.